IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Orchid Eyes European Purchase

10:54 AM MDT | July 27, 2007 | Chemical Week Editorial Staff

Pharma company Orchid Chemicals & Laboratories (Chennai, India) says it intends to make an acquisition in Europe as part of a strategy to gain access to the high-value international generic injectable drugs market. Orchid says it may issue shares to pay for the planned acquisition, depending on the size of the company that it buys. Orchid says it has yet to identify an acquisition target, but that it is looking for a “front-end” company with a sales force as well as divisions for quality control and post-marketing...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa